SCHEMBL6662890

SCHEMBL6662890

Cc1ccc2ncnc(Nc3cccc4ccccc34)c2c1

nearest known ligand 0.74

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 2/20 0.74
ALDH1A1 P00352 2/20 0.74
HPGD P15428 2/20 0.74
CYP1A2 P05177 1/20 0.74
CYP2D6 P10635 1/20 0.74
CYP2C9 P11712 1/20 0.74
CYP2C19 P33261 1/20 0.74
NPSR1 Q6W5P4 1/20 0.74
EGFR P00533 6/20 0.72
HTT P42858 4/20 0.67
MAPK1 P28482 3/20 0.64
KDM4E B2RXH2 1/20 0.64
FYN P06241 1/20 0.58
SRC P12931 1/20 0.58
MAPT P10636 2/20 0.54
LMNA P02545 1/20 0.54
HIF1A Q16665 1/20 0.54
ERBB2 P04626 2/20 0.52
NCOA1 Q15788 1/20 0.52
NCOA3 Q9Y6Q9 1/20 0.52

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27410804 0.85 ALDH1A1 (0.67) SMN1; SMN2ALDH1A1HPGDCYP1A2CYP2D6
Hydrochloric Acid SCHEMBL6182347 0.84 ALDH1A1 (0.66) SMN1; SMN2ALDH1A1HPGDCYP1A2CYP2D6
SCHEMBL6666099 0.82 HTT (0.68) SMN1; SMN2ALDH1A1HPGDCYP1A2CYP2D6
SCHEMBL5564779 0.82 HTT (0.64) SMN1; SMN2ALDH1A1HPGDCYP1A2CYP2D6
SCHEMBL6662659 0.80 HTT (0.67) SMN1; SMN2ALDH1A1HPGDCYP1A2CYP2D6
SCHEMBL5564640 0.80 HTT (0.62) SMN1; SMN2ALDH1A1HPGDCYP1A2CYP2D6
SCHEMBL6664779 0.79 HTT (0.64) SMN1; SMN2ALDH1A1HPGDCYP1A2CYP2D6
SCHEMBL6180170 0.79 EGFR (0.76) EGFR
SCHEMBL2101381 0.79 HTT (1.00) SMN1; SMN2ALDH1A1HPGDEGFRHTT
SCHEMBL5564611 0.79 KDR (0.71) SMN1; SMN2ALDH1A1HPGDEGFRHTT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2004013091-A2 4-ANILIDO SUBSTITUTED QUINAZOLINES AND USE THEREOF AS INHIBITORS OF EPIDERMAL GROWTH FACTOR RECEPTOR KINASES YISSUM RESEARCH DEVELOPMENT COMPANY OF THE HEBREW UNIVERSITY OF JERUSALEM (IL) 2004-02-12 WO claimed
WO-2004013091-A2 4-ANILIDO SUBSTITUTED QUINAZOLINES AND USE THEREOF AS INHIBITORS OF EPIDERMAL GROWTH FACTOR RECEPTOR KINASES YISSUM RESEARCH DEVELOPMENT COMPANY OF THE HEBREW UNIVERSITY OF JERUSALEM (IL) 2004-02-12 WO disclosed